New England Research & Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,595
| Closed | -$276K | – | 172 |
|
|
2024
Q2 | $276K | Sell |
2,595
-100
| -4% | -$10.6K | 0.13% | 152 |
|
|
2024
Q1 | $261K | Hold |
2,695
| – | – | 0.13% | 149 |
|
|
2023
Q4 | $272K | Hold |
2,695
| – | – | 0.14% | 143 |
|
|
2023
Q3 | $275K | Buy |
+2,695
| New | +$275K | 0.16% | 136 |
|
|
2020
Q4 | – | Sell |
-12,558
| Closed | -$1.09M | – | 164 |
|
|
2020
Q3 | $1.09M | Sell |
12,558
-112
| -0.9% | -$9.74K | 0.79% | 41 |
|
|
2020
Q2 | $1.11M | Buy |
12,670
+1,050
| +9% | +$91.7K | 0.79% | 43 |
|
|
2020
Q1 | $958K | Buy |
+11,620
| New | +$958K | 0.82% | 39 |
|
|
2019
Q2 | – | Sell |
-2,935
| Closed | -$253K | – | 177 |
|
|
2019
Q1 | $253K | Sell |
2,935
-112
| -4% | -$9.66K | 0.17% | 143 |
|
|
2018
Q4 | $234K | Sell |
3,047
-55
| -2% | -$4.22K | 0.18% | 138 |
|
|
2018
Q3 | $240K | Hold |
3,102
| – | – | 0.16% | 140 |
|
|
2018
Q2 | $210K | Sell |
3,102
-419
| -12% | -$28.4K | 0.14% | 157 |
|
|
2018
Q1 | $255K | Sell |
3,521
-335
| -9% | -$24.3K | 0.17% | 143 |
|
|
2017
Q4 | $290K | Sell |
3,856
-5,016
| -57% | -$377K | 0.21% | 120 |
|
|
2017
Q3 | $683K | Sell |
8,872
-8,147
| -48% | -$627K | 0.5% | 77 |
|
|
2017
Q2 | $1.27M | Sell |
17,019
-670
| -4% | -$50.1K | 0.94% | 31 |
|
|
2017
Q1 | $1.18M | Buy |
17,689
+6,217
| +54% | +$414K | 0.91% | 31 |
|
|
2016
Q4 | $749K | Buy |
11,472
+642
| +6% | +$41.9K | 0.59% | 60 |
|
|
2016
Q3 | $766K | Buy |
10,830
+642
| +6% | +$45.4K | 0.64% | 50 |
|
|
2016
Q2 | $753K | Buy |
+10,188
| New | +$753K | 0.65% | 47 |
|